{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T03:20:07Z","timestamp":1762917607529,"version":"3.45.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T00:00:00Z","timestamp":1682294400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Infection in Practice"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.clinpr.2023.100229","type":"journal-article","created":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T02:52:45Z","timestamp":1683168765000},"page":"100229","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Impact of common comorbidities on antimicrobial consumption and mortality amongst critically ill COVID-19 patients: A retrospective two center study in Saudi Arabia"],"prefix":"10.1016","volume":"19","author":[{"given":"Nada","family":"AlQadheeb","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanine","family":"AlMubayedh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"AlBadrani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdul","family":"Salam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mukhtar","family":"AlOmar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"AlAswad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"AlMualim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"AlQamariat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rasheed","family":"AlHubail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinpr.2023.100229_b0005","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.15537\/smj.2020.11.25495","article-title":"Clinical characteristics and in-hospital mortality of COVID-19 adult patients in Saudi Arabia","volume":"41","author":"Abohamr","year":"2020","journal-title":"Saudi Med. J."},{"key":"10.1016\/j.clinpr.2023.100229_b0010","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jsps.2021.06.005","article-title":"Demographics, comorbidities, and outcomes among young and middle-aged COVID-19 patients in Saudi Arabia","volume":"29","author":"Alali","year":"2021","journal-title":"Saudi Pharm. J."},{"key":"10.1016\/j.clinpr.2023.100229_b0015","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1080\/03007995.2021.1920900","article-title":"Effectiveness and safety of favipiravir compared to supportive care in moderately to critically ill COVID-19 patients: a retrospective study with propensity score matching sensitivity analysis","volume":"37","author":"Alamer","year":"2021","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.clinpr.2023.100229_b0020","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/j.jiph.2020.09.003","article-title":"Clinical characteristics of non-intensive care unit COVID-19 patients in Saudi Arabia: a descriptive cross-sectional study","volume":"13","author":"Al-Omari","year":"2020","journal-title":"J. Infect Public Health."},{"key":"10.1016\/j.clinpr.2023.100229_b0025","first-page":"9","article-title":"Demographic characteristics, comorbidities, and length of stay of COVID-19 patients admitted into intensive care units. In Saudi Arabia: a nationwide retrospective study","author":"Al-Otaiby","year":"2022","journal-title":"Front Med."},{"key":"10.1016\/j.clinpr.2023.100229_b0030","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.sjbs.2020.11.001","article-title":"SARS-CoV-2 associated COVID-19 in geriatric population: a brief narrative review","volume":"28","author":"Al-Zahrani","year":"2021","journal-title":"Saudi J. Biol. Sci."},{"key":"10.1016\/j.clinpr.2023.100229_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2020.104228","article-title":"In vitro testing of combined hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect","volume":"145","author":"Andreani","year":"2020","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.clinpr.2023.100229_b0040","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1111\/anae.15201","article-title":"Outcomes from intensive care in patients with COVID-19: a systematic review and meta-analysis of observational studies","volume":"75","author":"Armstrong","year":"2020","journal-title":"Anaesthesia."},{"key":"10.1016\/j.clinpr.2023.100229_b0045","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0140-6736(21)00461-X","article-title":"Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial","volume":"397","author":"Butler","year":"2021","journal-title":"Lancet."},{"key":"10.1016\/j.clinpr.2023.100229_b0050","unstructured":"COVID 19 Dashboard: Saudi Arabia [Internet], 2021a. [cited 19 August 2022]. <https:\/\/covid19.moh.gov.sa\/>."},{"key":"10.1016\/j.clinpr.2023.100229_b0055","unstructured":"Cucinotta, D., Vanelli, M., 2020. WHO declares COVID-19 a pandemic Acta Biomed. 91, 157. <https:\/\/doi.org\/10.23750\/abm.v91i1.9397>."},{"key":"10.1016\/j.clinpr.2023.100229_b0060","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0140-6736(20)31862-6","article-title":"Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial","volume":"396","author":"Furtado","year":"2020","journal-title":"Lancet."},{"key":"10.1016\/j.clinpr.2023.100229_b0065","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.antiviral.2013.09.015","article-title":"Favipiravir (T-705), a novel viral RNA polymerase inhibitor","volume":"100","author":"Furuta","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.clinpr.2023.100229_b0070","doi-asserted-by":"crossref","first-page":"72","DOI":"10.5582\/bst.2020.01047","article-title":"Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies","volume":"14","author":"Gao","year":"2020","journal-title":"Biosci. Trends."},{"key":"10.1016\/j.clinpr.2023.100229_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105949","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial","volume":"56","author":"Gautret","year":"2020","journal-title":"Int. J. Antimicrob. Agents."},{"key":"10.1016\/j.clinpr.2023.100229_b0080","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/aas.13701","article-title":"Characteristics, interventions, and longer term outcomes of COVID-19 ICU patients in Denmark\u2014a nationwide, observational study","volume":"65","author":"Haase","year":"2021","journal-title":"Acta Anaesthesiol. Scand."},{"key":"10.1016\/j.clinpr.2023.100229_b0085","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.clinpr.2023.100229_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2022.04.035","article-title":"The efficacy and adverse effects of favipiravir on COVID-19 patients: a systematic review and meta-analysis of published clinical trials and observational studies","author":"Hung","year":"2022","journal-title":"Int. J. Infect Dis."},{"key":"10.1016\/j.clinpr.2023.100229_b0095","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3389\/fpubh.2020.00152","article-title":"Gender differences in patients with COVID-19: focus on severity and mortality","author":"Jin","year":"2020","journal-title":"Front Public Health."},{"key":"10.1016\/j.clinpr.2023.100229_b0100","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4103\/atm.atm_178_21","article-title":"Characteristics and outcome of tertiary care critically ill COVID-19 patients with multiple comorbidities admitted to the intensive care unit","volume":"17","author":"Khalid","year":"2022","journal-title":"Ann. Thorac. Med."},{"key":"10.1016\/j.clinpr.2023.100229_b0105","doi-asserted-by":"crossref","unstructured":"Khan, A., Althunayyan, S., Alsofayan, Y., Alotaibi, R., Mubarak, A., Arafat, M., et al., 2020. Risk factors associated with worse outcomes in COVID-19: a retrospective study in Saudi Arabia East Mediterr Health J. 2020 1371 \u201380 10.26719\/emhj.20.130.","DOI":"10.26719\/emhj.20.130"},{"key":"10.1016\/j.clinpr.2023.100229_b0110","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1080\/14787210.2022.2011719","article-title":"Antimicrobial consumption in patients with COVID-19: a systematic review and meta-analysis","volume":"20","author":"Khan","year":"2022","journal-title":"Exp. Rev. Anti Infect Ther."},{"key":"10.1016\/j.clinpr.2023.100229_b0115","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/jcpt.13305","article-title":"Observational study of the effects of Favipiravir vs Lopinavir\/Ritonavir on clinical outcomes in critically Ill patients with COVID-19","volume":"46","author":"Kocayi\u011fit","year":"2021","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.clinpr.2023.100229_b0120","unstructured":"Michelen, M., Jones, N., Stavropoulou, C., 2022. In patients of COVID-19, what are the symptoms and clinical features of mild and moderate cases? \u2013 The Centre for Evidence-Based Medicine [Internet]. The Centre for Evidence-Based Medicine. [Online]. <https:\/\/www.cebm.net\/covid-19\/in-patients-of-covid-19-what-are-the-symptoms-and-clinical-features-of-mild-and-moderate-case\/>."},{"key":"10.1016\/j.clinpr.2023.100229_b0125","doi-asserted-by":"crossref","first-page":"e042008","DOI":"10.1136\/bmjopen-2020-042008","article-title":"Epidemiology, clinical characteristics and treatment of critically ill patients with COVID-19: a protocol for a living systematic review","volume":"11","author":"Milovanovic","year":"2021","journal-title":"BMJ Open."},{"key":"10.1016\/j.clinpr.2023.100229_b0130","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.hrtlng.2020.10.013","article-title":"Outcomes of patients with COVID-19 in. the intensive care unit in Mexico: a multicenter observational study","volume":"50","author":"\u00d1amendys-Silva","year":"2021","journal-title":"Heart Lung."},{"key":"10.1016\/j.clinpr.2023.100229_b0135","doi-asserted-by":"crossref","unstructured":"Pastick, K.A., Okafor, E.C., Wang, F., Lofgren, S.M., Skipper, C.P., Nicol, M.R., et al., 2020. Hydroxychloroquine and chloroquine for treatment of SARS-CoV-2 (COVID-19). Open Forum Infect Dis. 2020;7:ofaa130. Oxford University Press, US. <https:\/\/doi.org\/10.1093\/ofid\/ofaa130>.","DOI":"10.1093\/ofid\/ofaa130"},{"key":"10.1016\/j.clinpr.2023.100229_b0140","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1056\/NEJMoa2022926","article-title":"Effect of hydroxychloroquine in hospitalized patients with Covid-19","volume":"383","author":"RECOVERY Collaborative Group","year":"2020","journal-title":"NEJM."},{"key":"10.1016\/j.clinpr.2023.100229_b0145","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0140-6736(21)00149-5","article-title":"Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial","volume":"397","author":"RECOVERY Collaborative Group","year":"2021","journal-title":"Lancet."},{"key":"#cr-split#-10.1016\/j.clinpr.2023.100229_b0150.1","unstructured":"Reuters, T., 2020. Russia approves first COVID-19 prescription drug for sale in pharmacies [Internet]. Thomson Reuters"},{"key":"#cr-split#-10.1016\/j.clinpr.2023.100229_b0150.2","unstructured":"2020 [cited 2023 Apr 9]. <https:\/\/www.reuters.com\/article\/us-health-coronavirus-russia-rpharm-idUSKBN26917Z>."},{"key":"10.1016\/j.clinpr.2023.100229_b0155","first-page":"5","article-title":"Hydroxychloroquine prophylaxis and treatment is ineffective in macaque and hamster SARS-CoV-2 disease models","author":"Rosenke","year":"2020","journal-title":"Jci Insight."},{"key":"10.1016\/j.clinpr.2023.100229_b0160","first-page":"E33","article-title":"Characteristics, management and outcomes of critically ill COVID-19 patients admitted to ICU in hospitals in Bangladesh: a retrospective study","volume":"62","author":"Saha","year":"2021","journal-title":"J. Prev. Med. Hyg."},{"key":"10.1016\/j.clinpr.2023.100229_b0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12985-020-01412-z","article-title":"Favipiravir versus other antiviral or standard of care for COVID-19 treatment: a rapid systematic review and meta-analysis","volume":"17","author":"Shrestha","year":"2020","journal-title":"Virol. J."},{"key":"10.1016\/j.clinpr.2023.100229_b0170","article-title":"The role of organizational characteristics on the outcome of COVID-19 patients admitted to the ICU in Belgium","volume":"2","author":"Taccone","year":"2021","journal-title":"Lancet Reg. Health Eur."},{"key":"10.1016\/j.clinpr.2023.100229_b0175","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/cpt.2251","article-title":"Japan\u2019s drug regulation during the COVID-19 pandemic: lessons from a case study of favipiravir","volume":"111","author":"Ueda","year":"2022","journal-title":"Clin. Pharmacol. Ther."},{"key":"#cr-split#-10.1016\/j.clinpr.2023.100229_b0180.1","doi-asserted-by":"crossref","unstructured":"Vaidyanathan, G., 2020. Scientists criticize use of unproven COVID drugs in India [Internet]. Nature News. Nature Publishing Group","DOI":"10.1038\/d41586-020-03105-7"},{"key":"#cr-split#-10.1016\/j.clinpr.2023.100229_b0180.2","unstructured":"2020 [cited 2023 Apr 9]. <https:\/\/www.nature.com\/articles\/d41586-020-03105-7>."},{"key":"10.1016\/j.clinpr.2023.100229_b0185","first-page":"13","article-title":"Characteristics and risk factors associated with mortality in critically ill patients with COVID-19","author":"Vogels","year":"2021","journal-title":"Cureus."},{"key":"10.1016\/j.clinpr.2023.100229_b0190","unstructured":"WHO Coronavirus (COVID-19) Dashboard [Internet]. Covid19.who.int. 2021 [cited 19 August 2022]. <https:\/\/covid19.who.int\/>."},{"key":"10.1016\/j.clinpr.2023.100229_b0195","unstructured":"World Health Organization, 2021. 2021 aware classification [Internet]. [cited 7 Dec 2022]. <https:\/\/www.who.int\/publications\/i\/item\/2021-aware-classification>."},{"key":"10.1016\/j.clinpr.2023.100229_b0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12959-021-00284-9","article-title":"Prevalence and risk factors of thrombotic events on patients with COVID-19: a systematic review and meta-analysis","volume":"19","author":"Xiong","year":"2021","journal-title":"Thromb. J."},{"key":"10.1016\/j.clinpr.2023.100229_b0205","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S2213-2600(20)30079-5","article-title":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","volume":"8","author":"Yang","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.clinpr.2023.100229_b0210","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet."}],"container-title":["Clinical Infection in Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590170223000122?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590170223000122?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T03:07:01Z","timestamp":1762916821000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590170223000122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":44,"alternative-id":["S2590170223000122"],"URL":"https:\/\/doi.org\/10.1016\/j.clinpr.2023.100229","relation":{},"ISSN":["2590-1702"],"issn-type":[{"type":"print","value":"2590-1702"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of common comorbidities on antimicrobial consumption and mortality amongst critically ill COVID-19 patients: A retrospective two center study in Saudi Arabia","name":"articletitle","label":"Article Title"},{"value":"Clinical Infection in Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinpr.2023.100229","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd on behalf of British Infection Association.","name":"copyright","label":"Copyright"}],"article-number":"100229"}}